• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者报告数据整合用于嗜酸性粒细胞性食管炎的管理。

Patient reported data integration for management of Eosinophilic Esophagitis.

机构信息

Pediatric Gastroenterology & Nutrition, Geisinger, Danville, PA, USA.

Biomedical and Translational Informatics, Geisinger, Danville, PA, USA.

出版信息

Dis Esophagus. 2022 Oct 14;35(10). doi: 10.1093/dote/doac012.

DOI:10.1093/dote/doac012
PMID:35265973
Abstract

Eosinophilic Esophagitis (EoE) is an esophageal allergic inflammatory disorder triggered by food proteins. Symptoms of EoE are variable within and between individuals. Presenting symptoms may include dysphagia, food bolus impaction, dyspepsia, or more subtle symptoms such as feeding disorders, regurgitation sensation, or nausea. The development and validation of a pediatric EoE patient self-reported and parent proxy-reported outcome symptom scoring tool was created by Franciosi et al. published in BMJ 2011, titled the Pediatric Eosinophilic Esophagitis Symptom Score (PEESS™ v2.0). To date, its use is largely for research purposes. We propose to evaluate the implementation of the PEESS™ v2.0 in a prospective interventional controlled clinical practice. The study included 620 patients over an 18-month period. Surveys were delivered and administered digitally every month through the MyGeisinger.org Patient Portal. Our analysis demonstrated symptom severity and symptom frequency scores significantly improved over time. However, counter to our hypothesis, patients who completed the PEESS™v2.0 ultimately had higher EoE-related health care utilization of office visits and endoscopies compared with those who did not complete the PEESS™v2.0. This could be related to greater awareness of disease activity and/or increased willingness to seek care. Our study, in the context of mobile health tool and patient-reported outcome trends, represents an opportunity for improved disease monitoring at-home within the field of eosinophilic gastrointestinal diseases.

摘要

嗜酸粒细胞性食管炎 (EoE) 是一种由食物蛋白引发的食管过敏性炎症性疾病。EoE 的症状在个体之间和个体内部存在差异。其表现症状可能包括吞咽困难、食物团块嵌塞、消化不良,或更微妙的症状,如喂养障碍、反流感或恶心。由 Franciosi 等人发表在 2011 年的《英国医学杂志》上的研究创建了一种儿科嗜酸粒细胞性食管炎患者自我报告和家长代理报告的结局症状评分工具,即儿科嗜酸粒细胞性食管炎症状评分 (PEESS™ v2.0)。迄今为止,它的应用主要是为了研究目的。我们拟在一项前瞻性干预性对照临床实践中评估 PEESS™ v2.0 的实施情况。该研究在 18 个月的时间内纳入了 620 名患者。通过 MyGeisinger.org 患者门户每月以数字化方式进行调查和管理。我们的分析表明,症状严重程度和症状频率评分随时间显著改善。然而,与我们的假设相反,完成了 PEESS™ v2.0 的患者最终比未完成 PEESS™ v2.0 的患者有更高的与 EoE 相关的医疗保健利用率,包括就诊次数和内镜检查。这可能与对疾病活动的认识增加和/或更愿意寻求医疗护理有关。在移动医疗工具和患者报告结果趋势的背景下,我们的研究代表了在家中改善嗜酸细胞性胃肠道疾病监测的机会。

相似文献

1
Patient reported data integration for management of Eosinophilic Esophagitis.患者报告数据整合用于嗜酸性粒细胞性食管炎的管理。
Dis Esophagus. 2022 Oct 14;35(10). doi: 10.1093/dote/doac012.
2
Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease.小儿嗜酸性粒细胞性食管炎症状评分(PEESS v2.0)可识别该疾病关键临床特征的组织学和分子学关联。
J Allergy Clin Immunol. 2015 Jun;135(6):1519-28.e8. doi: 10.1016/j.jaci.2015.03.004.
3
Reliability and Validity Study of Turkish Version of Pediatric Eosinophilic Esophagitis Symptom Scores® (Tr-PEESS v2.0) Led to Development of a New Pediatric Eosinophilic Esophagitis Scale: GaziESAS.土耳其版儿童嗜酸性食管炎症状评分量表(Tr-PEESS v2.0)的信度和效度研究促成了一种新的儿童嗜酸性食管炎量表的发展:GaziESAS。
Turk J Gastroenterol. 2021 Apr;32(4):365-373. doi: 10.5152/tjg.2020.20674.
4
Eosinophilic Esophagitis Symptom Scores Are High in Children Without Eosinophilic Disease.嗜酸性粒细胞性食管炎症状评分在无嗜酸性粒细胞疾病的儿童中较高。
J Pediatr Gastroenterol Nutr. 2022 Mar 1;74(3):396-401. doi: 10.1097/MPG.0000000000003324.
5
Characterization of Eosinophilic Esophagitis From the European Pediatric Eosinophilic Esophagitis Registry (pEEr) of ESPGHAN.ESPghan 欧洲儿科嗜酸性食管炎注册研究(pEEr)对嗜酸性食管炎的特征描述。
J Pediatr Gastroenterol Nutr. 2022 Sep 1;75(3):325-333. doi: 10.1097/MPG.0000000000003530. Epub 2022 Aug 9.
6
Clinicopathological Differences between Eosinophilic Esophagitis and Asymptomatic Esophageal Eosinophilia.嗜酸性粒细胞性食管炎与无症状性食管嗜酸性粒细胞增多症的临床病理差异。
Intern Med. 2022 May 1;61(9):1319-1327. doi: 10.2169/internalmedicine.8241-21. Epub 2021 Oct 19.
7
Esophageal Eosinophilia Is Common Among Relatives of Eosinophilic Esophagitis Patients.食管嗜酸性粒细胞增多症在嗜酸性食管炎患者的亲属中很常见。
Clin Gastroenterol Hepatol. 2022 May;20(5):e957-e963. doi: 10.1016/j.cgh.2020.11.023. Epub 2020 Nov 19.
8
Development of a validated patient-reported symptom metric for pediatric eosinophilic esophagitis: qualitative methods.儿童嗜酸性食管炎患者报告症状指标的验证:定性方法。
BMC Gastroenterol. 2011 Nov 18;11:126. doi: 10.1186/1471-230X-11-126.
9
Clinical Evaluation of the Adult with Eosinophilic Esophagitis.嗜酸性粒细胞性食管炎成人患者的临床评估。
Immunol Allergy Clin North Am. 2024 May;44(2):185-196. doi: 10.1016/j.iac.2023.12.006. Epub 2024 Jan 11.
10
Increasing Age at the Time of Diagnosis and Evolving Phenotypes of Eosinophilic Esophagitis Over 20 Years.20年来嗜酸性粒细胞性食管炎诊断时年龄的增加及表型演变
Dig Dis Sci. 2024 Feb;69(2):521-527. doi: 10.1007/s10620-023-08165-z. Epub 2023 Nov 15.

引用本文的文献

1
A scoping review of the electronic collection and capture of patient reported outcome measures for children and young people in the hospital setting.关于医院环境中儿童和青少年患者报告结局测量的电子收集与获取的范围综述。
PLOS Digit Health. 2025 Jan 6;4(1):e0000704. doi: 10.1371/journal.pdig.0000704. eCollection 2025 Jan.
2
A Narrative Review of Patient-Reported Outcome Measures and Their Application in Recent Pediatric Surgical Research: Advancing Knowledge and Offering New Perspectives to the Field.患者报告结局测量及其在近期小儿外科学研究中的应用的叙述性综述:为该领域的知识进步和新视角提供支持。
Eur J Pediatr Surg. 2024 Apr;34(2):143-161. doi: 10.1055/s-0043-1778108. Epub 2024 Jan 25.
3
Is the Pediatric Eosinophilic Esophagitis Symptom Score v2.0 reliable for telemedicine?
儿科嗜酸性食管炎症状评分 v2.0 适用于远程医疗吗?
Turk J Med Sci. 2023 Aug;53(4):859-864. doi: 10.55730/1300-0144.5649. Epub 2023 Aug 18.